Search Results - "Fırat, Dinçer"

20. Yüzyılda Türk onkolojisine bakış: Prof. Dr. Dinçer Fırat, Prof. Dr. Münir Kınay, Prof. Dr. Tezer Kutluk, Prof. Dr. Münevver Büyükpamukçu ; editör, Prof. Dr. Dinçer Fırat by Fırat, Dinçer

Get more information

Türkiye ve dünyada kanser ölümleri: Cancer mortality in Turkey and the world, 1980-1981 / Dinçer Fırat by Fırat, Dinçer

Get more information

Türkiye'de kanser istatistikleri: Cancer statistics in Turkey / Prof. Dr. Dinçer Fırat by Fırat, Dinçer

Get more information

Klinik onkoloji: editörler by C. D. Sherman, D. K. Hossfeld, K. C. Calman, S. Eckhardt, I. Elsebai, J.P. Paunier, B. Salvadori, D. Fırat by Hossfeld, D. K, Sherman, Charles D, Fırat, Dinçer

Get more information

"The Turkish Journal of Cancer" A long journey from hand typesetting to electronic printing by Dinçer Firat

Get full text

Klinik onkoloji: editörler, by D. K. Hossfeld, C. D. Sherman, R. R. Love, F.X. Bosch; çeviri editörleri, D. Fırat, F. Sarıalioğlu, A. Kars by Hossfeld, D. K, Sherman, Charles D, Love, R. R, Bosch, F.X, Fırat, Dinçer, Kars, Ayşe, Sarıalioğlu, Faik

Get more information

Primary breast lymphomas--a retrospective analysis of twelve cases by Barişta, I, Baltali, E, Tekuzman, G, Kars, A, Ruacan, S, Ozişik, Y, Güler, N, Güllü, I H, Atahan, I L, Firat, D

“…This study was undertaken to define the natural history and treatment results of patients with primary breast non-Hodgkin's lymphoma (NHL). Twelve female…”
Get more information

Haemostatic changes; plasma levels of alpha2-antiplasmin-plasmin complex and thrombin-antithrombin III complex in female breast cancer by Ozyilkan, O, Baltali, E, Ozdemir, O, Tekuzman, G, Kirazli, S, Firat, D

“…Disorders of hemostasis in patients with malignancies are based on several mechanisms, such as ability of the tumor to alter the coagulation system by…”
Get more information

Non‐Hodgkin's Lymphomas in Turkey: Eighteen Years’Experience at the Hacettepe University by Barista, Ibrahim, Tekuzman, Gülten, Firat, Dinçer, Baltali, Esmen, Kansu, Emin, Kars, Ayse, Özisik, Yavuz, Ruacan, Sevket, Uzunalimoglu, Bedri, Karaagaoglu, Ergun

“…In this retrospective study, 470 patients with non‐Hodgkin's lymphoma (NHL) who had been followed in the Hacettepe University Medical Oncology Department…”
Get full text

Primary central nervous system lymphoma presenting with multiple myeloma-like clinical picture by ÇELIK, ISMAIL, BASÇIL, NESLIHAN, BARISTA, IBRAHIM, GÜLLÜ, IBRAHIM, TEKUZMAN, GÜLTEN, FIRAT, DINÇER

“…Primary cerebral lymphoma is a unique and infrequent CNS malignancy in which the B lymphocyte subtype constitutes most cases. 1 B cell neoplasms other than…”
Get full text

Combination of docetaxel and doxorubicin as first-line chemotherapy in metastatic breast cancer by Baltali, E, Ozişik, Y, Güler, N, Firat, D, Altundağ, K

“…Docetaxel (Taxotere) and doxorubicin have previously demonstrated a significant antitumor activity in patients with metastatic breast cancer. Furthermore, a…”
Get full text

The significance of the bone marrow biopsy pattern in chronic lymphocytic leukemia: A prognostic dilemma by Zengin, Nurullah, Kars, Ayşe, Sungur, Arzu, Zengin, Neslihan İnci, Hayran, Mutlu, Tekuzman, Gülten, Kansu, Emin, Ruacan, Şevket, Fırat, Dinçer

“…Although bone marrow biopsy pattern (BMBP) has long been suggested to be an independent prognostic factor in chronic lymphocytic leukemia (CLL), conflicting…”
Get full text

Tıp Fakültelerinde Mezuniyet Öncesi Onkoloji Eğitimi Simpozyumu: 4 Kasım 1984, Hacettepe Üniversitesi Onkoloji Enstitüsü = Symposium on Undergraduate Oncology Education in Medical Schools : November 4, 1984, University of Hacettepe, Institute of Oncology, Ankara / editörler, Dinçer Fırat, Emin Kansu by Kansu, Emin, Fırat, Dinçer

Get more information

The correlates of benefit from neoadjuvant chemotherapy before surgery in non-small-cell lung cancer: a metaregression analysis by Bozcuk, Hakan, Abali, Huseyin, Coskun, Senol

“…Although neoadjuvant chemotherapy (NCT) is widely used, it is not clear which subgroup of locally advanced non-small-cell lung cancer (NSCLC) patients should…”
Get full text

Tobacco and cancer in Turkey by Firat, D

“…Although the smoking epidemic is decreasing steadily in other parts of the world, it continues to spread at an accelerated rate in underdeveloped and…”
Get more information

Cancer Therapy During Ramadan by ÇELIK, ISMAIL, BARISTA, IBRAHIM, FIRAT, DINÇER

“…Celik and others discuss the problem of treating patients with cancer who are determined to abide by their religious custom of fasting during Ramadan in…”
Get full text

Non-Hodgkin's lymphomas of the tonsil: a retrospective analysis of twenty-eight patients with primary tonsillary lymphoma by Barişta, I, Tekuzman, G, Güllü, I, Baltali, E, Kars, A, Ozişik, Y, Güler, N, Celik, I, Atahan, I L, Firat, D

“…To analyze the clinical and therapeutic aspects of patients with primary tonsillary non-Hodgkin's lymphoma. Twenty-eight patients with primary tonsillary…”
Get more information

Treatment of advanced soft tissue sarcomas with ifosfamide and doxorubicin combination chemotherapy by Barişta, İbrahi̇m, Tekuzman, Gülten, Yalçin, Şuayi̇b, Güllü, İbrahi̇m, Güler, Ni̇lüfer, Özişik, Yavuz, Kars, Ayşe, Çeli̇k, İsmai̇l, Türker, Alev, Altundağ, Kadri̇, Zengi̇n, Nurullah, Üner, Ayşegül, Baltali, Eşmen, Firat, Di̇nçer

“…Our objective was to assess the efficacy of a standard dose ifosfamide and doxorubicin containing regimen in the treatment of advanced soft tissue sarcomas…”
Get full text

A comparison of two nonsteroidal antiinflammatory drugs (diflunisal versus dipyrone) in the treatment of moderate to severe cancer pain a randomized crossover study by YALCIN, S, GÜLLÜ, I. H, TEKUZMAN, G, SAVAS, C, FIRAT, D

“…The efficacy of diflunisal in cancer pain was evaluated and compared with dipyrone. Diflunisal was given at the dosage of 500 mg perorally twice a day, and…”
Get full text

Paclitaxel and doxorubicin combination in the first-line treatment of metastatic breast cancer by Baltali, Eşmen, Altundağ, M Kadri, Güler, Nilüfer, Ozişik, Yavuz, Firat, Dinçer, Baran, Ismet, Tekuzman, Gülten

“…Anthracyclines and taxanes are currently the most effective drugs in the treatment of metastatic breast carcinoma. The aim of this study was to determine the…”
Get full text